Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Atomo Diagnostics Joins With Access Bio To Globalize HIV POC Testing

Executive Summary

Australian firm Atomo Diagnostics and US-based Access Bio have joined forces to expand point-of-care HIV testing into markets beyond their domestic borders. Under the agreement, Access Bio will add Atomo's all-in-one rapid HIV diagnostic test to its infectious disease portfolio and market it to the professional-use segment.

Advertisement

Related Content

Atomo Takes Rapid, All-In-One Diagnostic Device Platform To A&E Pregnancy Testing Market

Topics

Advertisement
UsernamePublicRestriction

Register

MT122113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel